ABIVAX Société Anonyme (AAVXF)
OTCMKTS · Delayed Price · Currency is USD
86.10
0.00 (0.00%)
Sep 18, 2025, 8:00 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $6.17 billion as of September 22, 2025. Its market cap has increased by 740.20% in one year.
Market Cap
6.17B
Enterprise Value
6.22B
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$86.10
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 225.47M to 6.17B, an increase of 2,637.63%. That is a compound annual growth rate of 38.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 6.17B | 1,292.50% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 791.41M |
| Tian'an Technology Group | 728.29M |
| Elite Pharmaceuticals | 667.60M |
| Glass House Brands | 551.67M |
| Northwest Biotherapeutics | 376.65M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 367.01M |
| American Oncology Network | 347.09M |